|
Tracy, R P; Rubin, D Z; Mann, K G et al. (1997) Thrombolytic therapy and proteolysis of factor V. J Am Coll Cardiol 30:716-24
|
|
Messier, T L; Wong, C Y; Bovill, E G et al. (1996) Factor X Stockton: a mild bleeding diathesis associated with an active site mutation in factor X. Blood Coagul Fibrinolysis 7:5-14
|
|
Church, W R; Messier, T L; Ouellette, L A et al. (1994) A kringle-specific monoclonal antibody. Hybridoma 13:423-9
|
|
Howard, P R; Bovill, E G; Pike, J et al. (1994) Factor VII antigen levels in a healthy blood donor population. Thromb Haemost 72:21-7
|
|
Becker, R C; Terrin, M; Ross, R et al. (1994) Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. Ann Intern Med 120:638-45
|
|
Bovill, E G; Soll, R F; Lynch, M et al. (1993) Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate. Blood 81:77-83
|
|
Krishnaswamy, S; Nesheim, M E; Pryzdial, E L et al. (1993) Assembly of prothrombinase complex. Methods Enzymol 222:260-80
|
|
Lawson, J H; Krishnaswamy, S; Butenas, S et al. (1993) Extrinsic pathway proteolytic activity. Methods Enzymol 222:177-95
|
|
Krishnaswamy, S; Field, K A; Edgington, T S et al. (1992) Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem 267:26110-20
|
|
Taylor Jr, F B; Hoogendoorn, H; Chang, A C et al. (1992) Anticoagulant and fibrinolytic activities are promoted, not retarded, in vivo after thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C. Blood 79:1720-8
|
Showing the most recent 10 out of 108 publications
